CollPlant Biotechnologies Ratios (2017-2025) | CLGN

Ratios Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 94.55%88.89%63.19%66.07%65.98%29.29%23.60%5.01%20.05%22.00%9.11%65.26%51.08%93.89%37.92%-1,428,571.43%-76.77%34.85%-142.20%-6.90%24.94%93.96%0.00%-158.53%-456.12%-115.26%-6,700.00%-65.85%90.85%-3,910,614.53%-249.35%
EBT Margin 619.64%824.89%601.65%633.04%-54.94%352.36%395.54%-52.43%-1,651.03%-276.85%-231.11%18,369,672.13%-498.91%69.62%-431.69%51,361.43%-62,124.19%-6,340.91%-4,099.08%-8,062.07%812.70%55.74%-0.01%-1,694.98%4,417.35%1,769.48%-113,550.00%-2,423.17%80.19%1,775.42%-4,554.55%
EBIT Margin 649.09%927.11%763.19%683.04%-17.36%257.07%290.59%-257.29%-591.34%-280.30%-232.44%17,695,274.83%-91.27%69.14%-443.27%-2,210.00%-1,227.10%-6,340.91%-4,099.08%-8,062.07%812.70%55.74%-0.01%-1,694.98%4,417.35%1,769.48%-113,550.00%-2,423.17%80.19%1,775.42%-4,554.55%
EBITDA Margin 619.64%-929.78%944.51%579.91%35.41%-343.10%250.83%472.90%1,001.14%-280.30%-232.44%17,695,274.83%-91.27%69.14%-443.27%-2,210.00%-1,227.10%-6,340.91%-4,099.08%-8,062.07%812.70%55.74%-0.01%-1,694.98%4,417.35%1,769.48%-113,550.00%-2,423.17%80.19%1,775.42%-4,554.55%
Operating Margin 649.09%927.11%763.19%683.04%-17.36%257.07%290.59%-257.29%-591.34%-280.30%-232.44%17,695,274.83%-91.27%69.14%-443.27%-2,210.00%-1,227.10%-6,340.91%-4,099.08%-8,062.07%812.70%55.74%-0.01%-1,694.98%4,417.35%1,769.48%-113,550.00%-2,423.17%80.19%1,775.42%-4,554.55%
Net Margin 619.64%824.89%601.65%633.04%-54.94%352.36%395.54%-52.43%-1,651.03%-276.85%-231.11%18,369,672.13%-498.91%69.62%-431.69%51,361.43%-62,124.19%-6,340.91%-4,099.08%-8,062.07%812.70%55.74%-0.01%-1,694.98%4,417.35%1,769.48%-113,550.00%-2,423.17%80.19%1,775.42%-4,554.55%
FCF Margin -553.33%-793.41%-440.18%75.06%-41.75%-233.83%-183.36%-296.58%-410.51%-194.05%37,970.11%-65.47%77.52%-454.12%-1,580.00%-320.00%-5,413.64%-2,638.53%-21,420.69%-763.28%-33.45%0.02%-707.69%-3,235.71%-1,496.39%-82,700.00%-2,076.22%-56.35%-1,361.45%-3,735.06%
Efficiency
Inventory Average 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.44B0.44B0.00B0.00B0.00B0.64B0.64B0.00B540.50B540.50B0.00B0.00B0.72B0.72B0.00B0.75B0.75B0.32B0.32B0.23B0.23B0.34B0.34B
Assets Average 0.02B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.03B0.05B0.05B0.05B0.05B0.04B0.04B0.04B0.04B0.02B0.02B0.02B0.01B0.01B0.01B0.01B0.01B0.02B
Invested Capital 0.01B0.00B0.01B0.00B0.05B0.03B0.03B0.01B
Asset Utilization Ratio 0.150.670.530.550.560.200.200.210.160.643.940.770.400.300.020.010.010.010.020.280.00B0.00B0.00B0.00B0.050.050.260.280.16
Leverage & Solvency
Interest Coverage Ratio 17.685.62255.00-0.36-2.62-293.501.26-0.56426.75956.50-66.73-0.70-527.68382.880.39
Debt to Equity -0.44-1.45-0.44-0.74
Debt Ratio 0.450.72-0.35-0.54-0.270.500.62-0.31-0.55-0.11-0.23-0.13-0.31186.440.150.11
Equity Ratio 0.620.380.530.410.880.850.830.72
Times Interest Earned 17.685.62255.00-0.36-2.62-293.501.26-0.56426.75956.50-66.73-0.70-527.68382.880.39
Valuation
Enterprise Value -0.00B-0.01B-0.01B-0.00B-0.01B-0.00B-0.00B-0.01B-0.17B-0.01B-0.00B-0.01B-0.00B-0.05B-0.02B-0.03B-213.01B-0.04B-0.04B-0.03B-0.20B-0.03B-0.02B-0.25B-0.03B-0.27B-0.02B-0.27B-0.01B-0.26B-0.01B-0.01B
Return Ratios
Return on Sales 6.20%8.25%6.02%6.33%-0.55%3.52%3.96%-0.52%-16.51%-2.77%-2.31%183,696.72%-4.99%0.70%-4.32%513.61%-621.24%-105.08%-63.41%-40.99%-80.62%8.13%0.56%0.00%-16.95%44.17%17.69%-1,135.50%-24.23%0.80%17.75%-45.55%
Return on Capital Employed 0.81%0.56%-0.13%-0.47%-0.82%81.85%86.07%355.49%29.89%-0.03%0.00%-0.13%-0.17%-0.22%-0.27%-0.29%0.00%0.00%-0.03%0.02%-0.09%-0.09%0.03%-0.37%-0.62%-0.20%
Return on Assets 0.98%0.26%0.22%0.33%0.15%-0.26%-0.58%-0.94%63.32%61.63%135.73%26.82%0.89%-2.17%-2.40%-2.60%-4.65%-0.24%-0.27%0.00%0.00%-0.03%0.02%-0.07%-0.07%0.02%-0.26%-0.42%-0.17%